Nath Bio-Genes Reports Mixed Financial Results Amidst Sales Growth and Declining Profits in March 2025

Nath Bio-Genes (India), a microcap player in the Agri-Seeds industry, has recently reported its financial results for the quarter ending March 2025. The evaluation changes reflect a notable shift in the company's financial standing, with the score adjusting to -15 from -10 over the past three months.
The financial results indicate some positive aspects for Nath Bio-Genes. Net sales for the quarter reached Rs 51.97 crore, showcasing a year-on-year growth of 20.75%, suggesting a favorable near-term sales trend. Additionally, the company's Debtors Turnover Ratio has improved, recorded at 4.10 times, marking the highest performance in the last five half-yearly periods, indicating a quicker settlement of debts.

Conversely, several challenges are evident in the financial data. Profit Before Tax less Other Income (PBT) has shown a significant decline, reported at Rs -2.29 crore, reflecting a very negative near-term trend. Profit After Tax (PAT) also decreased to Rs 1.48 crore, down 43.5% year-on-year. Furthermore, the Operating Profit Margin has reached its lowest point at 0.79%, indicating a decline in operational efficiency. The rising interest costs, now at Rs 8.25 crore, further complicate the financial landscape for the company.

For more insights, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.